🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A randomized, open-label, prospective, multicenter study designed to invest...
Status
Recruiting
Location
Phoenix Children's Hospital
Start Date
2019-02-28
Trial ID
NCT03684018
Treatments Being Tested
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested
This is a prospective open-label, uncontrolled, single-blind, pilot clinica...
Status
Completed
Location
University of Alberta
Start Date
2014-10
Trial ID
NCT02774239
Treatments Being Tested
All patients will receive the investigational medicinal product BP-SCIG 20%...
Status
Recruiting
Location
Municipal Non-Profit Enterprise "Cherkasy Regional Children's Hospital" of the Cherkasy Regional Council
Start Date
2025-12-17
Trial ID
NCT07346859
Treatments Being Tested
This study evaluates the efficacy and safety of efprezimod alfa in hospital...
Status
Completed
Location
Baptist Health Research Institute
Start Date
2020-04-24
Trial ID
NCT04317040
Treatments Being Tested
This Phase III clinical study is to test efficacy, safety and pharmacokinet...
Status
Completed
Location
Investigational site # 0104
Start Date
2016-10-04
Trial ID
NCT02810444
Treatments Being Tested
SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-30
Trial ID
NCT05238831
Treatments Being Tested
This multicenter, open-label, parallel-arm, non-randomized study is designe...
Status
Completed
Location
Clinical Research Center of Alabama
Start Date
2017-02-01
Trial ID
NCT03033745
Treatments Being Tested
This Phase IIb trial will compare effectiveness and safety of a multi-compo...
Status
Not Yet Recruiting
Location
University of Alabama at Birmingham
Start Date
2026-10-01
Trial ID
NCT07674745
Treatments Being Tested
The objective of this study is to assess the efficacy, tolerability, safety...
Status
Completed
Location
Study site
Start Date
2007-09
Trial ID
NCT00542997
Treatments Being Tested